Practice Committee
of the American Society for Reproductive Medicine does not recommend Metformin alone
for ovulation induction as a first line therapy in women with PCOS. The guidelines
were published in Journal Fertility and Sterility Epub ahead of print.
Metformin is
a biguanide used as an oral insulin lowering agent in type2 diabetes, but also
used enthusiastically in women with PCOS because of shared pathophysiology of
insulin resistance in both.
A review of
clinical data has however failed to support its use as first-line therapy in
PCOS and for treating hirsutism.
A review of
RCTs showed that metformin alone only increases the ovulation rate but letrozole
and clomiphene citrate alone are more effective in terms of ovulation,
pregnancy and live-birth rates.
When
Metformin alone was compared with Clomiphene alone, evidence suggested that it
is less effective for ovulation and live-birth rates.
Metformin is
recommended as a second line therapy in combination with gonadotrophins for clomiphene
citrate resistant and/or obese PCOS patients. However, there is good evidence
that live pregnancy rate remains the same with this combination.
Metformin
can only be used as first line therapy if facilities are not available to
monitor the more effective therapies of clomiphene citrate and letrozole.
A 2016 analysis of evidence to help WHO formulate global treatment guidelines for the
management of anovulatory infertility in women with polycystic ovary syndrome
(PCOS) also does not recommend metformin alone as first-line therapy. Its use
is recommended as an adjunct to GnRH-agonist long protocol IVF or ICSI
treatment to reduce the risk of ovarian hyperstimulation syndrome.
Metformin
should be stopped as soon as pregnancy is achieved because it does not help in
reducing routine pregnancy complications. The Endocrine Society and NICE Guidelines on PCOS state that the routine use of metformin during pregnancy in
women with PCOS is unwarranted, although it may be useful to treat gestational
diabetes, and therefore recommended against the use of metformin for the
prevention of pregnancy complications.
The issue of declining AMH: - Q.1.Is it true that AMH and also AFC is decreasing globally? If so what may be principal causes? Is such ill effect are anyway related to increasing environmental Pollution? Q.2.At what time the decline occurs in wmen who exhibit low AMH ,say at the age of 25 trs ( say 0.9). Does the damage of AMH occurs in embryonic life or foetal life? Any study on this aspect?? Q.3. The ways and means in preg period or prior to preg so that if foetus inside the womb is a female foetus her AMH will be near normal. Or else the decrees occurs in Toddler phase or at puberty? Q,4. Is decline of AMH is a global phenomenon like decline of sperm density and morphology??
ReplyDeleteI was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
ReplyDeleteliver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
treatment! This treatment is a breakthrough for all HBV carriers.